Latest 10-K annual reports

Advent Technologies Holdings, Inc. reported a reduced net loss and positive operating cash flow in 2024, driven by a strategic shift to joint development agreements, but faces substantial doubt about its ability to continue as a going concern due to insufficient cash, negative working capital, and significant legal liabilities.

VivoSim Labs, Inc. has strategically shifted its business focus to providing 3D human tissue models for drug testing, securing an initial $10 million from Eli Lilly for its former FXR program, while successfully regaining compliance with Nasdaq listing requirements.

Finnovate Acquisition Corp., a SPAC, reported a net loss for 2024 and continues to face significant challenges, including delisting from Nasdaq and substantial shareholder redemptions, as it repeatedly extends its deadline to complete a business combination with Scage International Limited.

Ameritek Ventures, Inc. reported a significant net income of $4.5 million for fiscal year 2024, primarily due to a one-time gain from the sale of Ecker Capital, LLC to a related party, while facing a 29% decline in operating revenue and acknowledging material weaknesses in its internal financial controls.

Nocera, Inc. has filed an amended annual report for 2024, restating prior interim financial statements due to errors in warrant liability calculations and asset misclassifications, revealing continued net losses and raising substantial doubt about its ability to continue as a going concern.

BARK, Inc. reported a slight revenue decrease for fiscal year 2025, but achieved its first full year of positive Adjusted EBITDA, driven by improved gross margins and significant growth in its Commerce segment, as it strategically shifts focus to consumables and services.

Altria Group, Inc. has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, primarily to incorporate the consolidated financial statements of its foreign equity investee, Anheuser-Busch InBev SA/NV, as required by SEC regulations.

Coeptis Therapeutics Holdings, Inc. has filed an amendment to its 2024 Annual Report on Form 10-K to include its previously omitted Executive Compensation Clawback Policy, ensuring compliance with SEC and Nasdaq rules.

One World Products, Inc. reported significant net losses and a going concern qualification for fiscal year 2024, driven by the liquidation of its Colombian cannabis operations and a strategic shift towards U.S. CBD sales and industrial hemp solutions for the automotive market.

The Crypto Company has filed an amended annual report for 2023, restating its financial statements to reflect significantly higher losses and a material weakness in internal controls, following the SEC's cease-and-desist order against its former auditor.

Destination XL Group, Inc. filed an amendment to its Annual Report on Form 10-K, detailing fiscal 2024 financial performance that fell below expectations, a significant reduction in executive compensation reflecting this underperformance, and updates on corporate governance practices.

UPAY, Inc. reported a significant 48.5% drop in revenues for the fiscal year ended February 28, 2025, alongside an increased working capital deficit and substantial cash used in operations, leading auditors to express substantial doubt about the company's ability to continue as a going concern.

Onconetix, Inc. reported a substantial net loss of $58.7 million for 2024, a significant working capital deficit, and explicit doubts about its ability to continue as a going concern, while abandoning its ENTADFI commercialization to focus on the Proclarix prostate cancer diagnostic.

American Resources Corporation's amended annual report for 2024 reveals a dramatic 97% drop in revenue, increased net losses, and a going concern warning, as the company shifts focus from coal mining to developing rare earth and metal recovery businesses.

American Vanguard Corporation has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, primarily to correct incorrect dates in its independent auditor's consent and to clarify the incorporation of information from its proxy statement.

Loop Industries, Inc. filed an amended annual report (10-K/A) to correct an audit report sentence, while detailing significant progress in its commercialization strategy through new partnerships in Europe and India, despite ongoing net losses and an equipment impairment charge.

Lionsgate Studios Corp. reports a net loss of $128.5 million for fiscal year 2025, reflecting the impact of its Starz separation, eOne acquisition integration, and strategic content shifts, while managing significant debt obligations.

NV5 Global, Inc. has filed an Amendment No. 2 to its Annual Report on Form 10-K for the fiscal year ended December 28, 2024, primarily to include previously omitted beneficial ownership information and updated Sarbanes-Oxley certifications.

Park Aerospace Corp. reported an 11% increase in net sales for fiscal year 2025, driven by aerospace market demand, but saw a 21% decline in net earnings due to a storm damage charge and a significant deferred tax provision on foreign earnings.

Phoenix Motor Inc. reported a net income of $7.9 million in 2024, primarily driven by a bargain purchase gain from the Proterra acquisition, despite continued operating losses and a Nasdaq delisting, as the company focuses on strategic integration and cost reduction.

Universal Corporation announced a 7% increase in consolidated revenues and a 5% rise in operating income for fiscal year 2025, driven by strong performance in both its Tobacco and Ingredients segments, despite a 21% drop in diluted earnings per share and the identification of a new material weakness in internal controls.

Streamline Health Solutions, Inc. has filed an amendment to its annual report, providing comprehensive details on corporate governance, executive compensation, and director appointments, while disclosing that named executive officers did not receive cash bonuses for fiscal year 2024 due to not meeting adjusted EBITDA targets.

Kirklands, Inc. filed an amendment to its annual report to include detailed information on executive compensation and corporate governance, disclosing a significant fiscal 2024 EBITDA loss and outlining its strategic partnership with Beyond, Inc.

Hamilton Lane Incorporated announced a significant surge in net income and revenues for fiscal year 2025, primarily fueled by a near-doubling of incentive fees and continued strong growth in assets under management and advisement.

eBay Inc. has filed an Amendment No. 1 to its 2024 Annual Report on Form 10-K to incorporate the financial statements of Adevinta ASA, a significant equity method investee, as required by SEC regulations.

TriSalus Life Sciences, an oncology-focused medical technology company, reported a significant reduction in net loss and strong revenue growth for the fiscal year ended December 31, 2024, but disclosed substantial doubt about its ability to continue as a going concern due to recurring losses and insufficient liquidity without further financing.

Bimergen Energy Corporation, formerly Bitech Technologies, reported a significant increase in net loss for fiscal year 2024, driven by operational expansion into utility-scale battery energy storage and solar projects following the acquisition of Emergen Energy LLC, while also announcing a new joint venture with RelyEZ Energy Group for 2 GW of BESS projects.

Kyndryl Holdings, Inc. announced a return to net income profitability and robust signings growth in fiscal year 2025, signaling progress in its strategic transformation despite a continued decline in overall revenue.

Canopy Growth Corporation reported a significant increase in net loss for fiscal year 2025, reaching C$604.1 million, despite improvements in gross margin and a reduction in Adjusted EBITDA loss, as the company continues its strategic shift towards an asset-right model and U.S. market entry.

iCoreConnect Inc. reported a doubling of its net loss to over $31 million in 2024, faces Nasdaq delisting, and has substantial doubt about its ability to continue as a going concern, despite revenue growth.